{"id":"etersalate","rwe":[{"pmid":"30226897","year":"2018","title":"Etersalate prevents the formations of 6Aβ16-22 oligomer: An in silico study.","finding":"","journal":"PloS one","studyType":"Clinical Study"},{"pmid":"2883981","year":"1987","title":"Effect of etersalate on human platelet responsiveness. A study in healthy volunteers.","finding":"","journal":"Arzneimittel-Forschung","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"daital","offLabel":[],"synonyms":["etersalate","eterilate","eterylate","etherylate","daital"],"timeline":[],"approvals":[],"brandName":"Daital","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells have locks on them, and Daital is a key that fits into one of those locks. When it binds, it can either turn the lock on or off, depending on the type of lock and the key's shape. However, since the target is unknown, we can't say exactly how Daital works or what it does when it binds.","oneSentence":"Daital works by binding to a specific target, but the exact mechanism is unknown.","technicalDetail":"Daital's mechanism of action is not well understood, and further research is needed to elucidate its pharmacological effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1070","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ETERSALATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:15:03.865007","biosimilars":[],"competitors":[],"genericName":"etersalate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"653GN04T2G","CHEBI":"CHEBI:135509","INN_ID":"5378","UMLSCUI":"C1880567","ChEMBL_ID":"CHEMBL2104226","PUBCHEM_CID":"44258","MESH_SUPPLEMENTAL_RECORD_UI":"C017297"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2018","pmid":"30226897","title":"Etersalate prevents the formations of 6Aβ16-22 oligomer: An in silico study.","journal":"PloS one"},{"date":"1987 Feb","pmid":"2883981","title":"Effect of etersalate on human platelet responsiveness. A study in healthy volunteers.","journal":"Arzneimittel-Forschung"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Daital (Etersalate) is a small molecule modality with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. Further information on its pharmacokinetics, safety, and efficacy is not available. As a result, it is difficult to provide a comprehensive summary of this compound. More research is needed to understand its potential therapeutic applications and risks.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}